GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Carl Zeiss Meditec AG (WBO:AFX) » Definitions » 3-Year ROIIC %

Carl Zeiss Meditec AG (WBO:AFX) 3-Year ROIIC % : 14.74% (As of Sep. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Carl Zeiss Meditec AG 3-Year ROIIC %?

3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year. Carl Zeiss Meditec AG's 3-Year ROIIC % for the quarter that ended in Sep. 2023 was 14.74%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Carl Zeiss Meditec AG's 3-Year ROIIC % or its related term are showing as below:

WBO:AFX's 3-Year ROIIC % is ranked better than
68.29% of 820 companies
in the Medical Devices & Instruments industry
Industry Median: -1.765 vs WBO:AFX: 14.74

Carl Zeiss Meditec AG 3-Year ROIIC % Historical Data

The historical data trend for Carl Zeiss Meditec AG's 3-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Carl Zeiss Meditec AG 3-Year ROIIC % Chart

Carl Zeiss Meditec AG Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
3-Year ROIIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.11 -0.32 18.33 14.79 14.74

Carl Zeiss Meditec AG Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
3-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 14.74 - - -

Competitive Comparison of Carl Zeiss Meditec AG's 3-Year ROIIC %

For the Medical Instruments & Supplies subindustry, Carl Zeiss Meditec AG's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Carl Zeiss Meditec AG's 3-Year ROIIC % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Carl Zeiss Meditec AG's 3-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Carl Zeiss Meditec AG's 3-Year ROIIC % falls into.



Carl Zeiss Meditec AG 3-Year ROIIC % Calculation

Carl Zeiss Meditec AG's 3-Year ROIIC % for the quarter that ended in Sep. 2023 is calculated as:

3-Year ROIIC %=3-Year Incremental Net Operating Profit After Taxes (NOPAT)**/3-Year Incremental Invested Capital**
=( 246.4021672 (Sep. 2023) - 122.6174112 (Sep. 2020) )/( 2730.198 (Sep. 2023) - 1890.586 (Sep. 2020) )
=123.784756/839.612
=14.74%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Carl Zeiss Meditec AG  (WBO:AFX) 3-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Carl Zeiss Meditec AG 3-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Carl Zeiss Meditec AG's 3-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Carl Zeiss Meditec AG Business Description

Address
Goschwitzer Strasse 51-52, Jena, TH, DEU, 07745
Carl Zeiss Meditec is one of the largest medical technology companies in the world, and it operates in two segments: ophthalmic devices and microsurgery. OPT, which made up 75% of sales in 2022, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.

Carl Zeiss Meditec AG Headlines

No Headlines